Navigation Links
Telik Announces First Quarter 2011 Financial Results
Date:5/16/2011

PALO ALTO, Calif., May 16, 2011 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2011.  The net loss for the quarter ended March 31, 2011 was $3.7 million, or $0.07 per share, compared with a net loss of $5.3 million, or $0.10 per share, for the same period in 2010.

Total research and development expenses (R&D) in the first quarter of 2011 were $1.7 million, compared to $2.8 million for the same period in 2010.  The decrease in R&D expenses was primarily due to lower headcount and related costs, lower clinical development expenditures and lower facility allocation cost as a result of the relocation of our corporate offices in the fourth quarter of 2010.

Total general and administrative expenses (G&A) in the first quarter of 2011 were $2.0 million, compared to $2.6 million for the same period in 2010.  The decrease in G&A expenses was primarily due to lower stock-based compensation expense, lower headcount and lower facility allocation cost.

The company anticipates its 2011 net cash utilization to be in the range of $14.0 million to $15.0 million, with total operating expenses in the range of $13.0 million to $15.0 million of which approximately 53% is expected to be R&D expense and 47% G&A expense.

As of March 31, 2011, cash, cash equivalents, restricted cash and investments totaled $20.2 million, compared with $24.1 million for the quarter ended December 31, 2010.

Telik continues to focus on advancing the clinical development of TELINTRA® for Myelodysplastic Syndrome (MDS) and other blood disorders.  Ongoing clinical trials for TELINTRA include a Phase 1 multicenter, dose escalation study in combination with lenalidomide (Revlimid®) in patients with low to intermediate-1 risk MDS and a Phase 2 randomized
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting
2. Telik Announces Presentation and Webcast at 10th Annual Needham Healthcare Conference
3. Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance
4. Telik Announces Presentation and Webcast at 13th Annual BIO CEO & Investor Conference
5. Telik Announces Presentation at American Society of Hematology Annual Meeting
6. Telik Announces Third Quarter 2010 Financial Results
7. Telik Awarded $1.2 Million in Grants for Qualifying Therapeutic Development Projects
8. Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
9. Telik Announces Publication of a Case Report of a Sustained Hematologic Response in Myelodysplastic Syndrome Following an Abbreviated Exposure to Oral Telintra(R) (Ezatiostat HCl)
10. Telik Announces Fourth Quarter and 2009 Year End Financial Results and 2010 Financial Guidance
11. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)...  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today that James ... has been elected to the Company,s Board of Directors, ... Anderson , Executive Chairman of CryoLife, stated, "Since joining the ... excellent leader who is well positioned to maximize CryoLife,s ...
(Date:10/22/2014)... LOUIS , Oct. 21, 2014  Early ... often subtle or unnoticed, but new technology, coupled ... outcomes and leading to earlier detection of eye ... affects 29 million Americans. If left untreated, these ... even blindness. Recently, optometric researchers ...
(Date:10/22/2014)... 22, 2014 InVivo Therapeutics Holdings Corp. (OTCQB: ... is revolutionizing spinal cord injury (SCI) treatment with their ... outperform in tissue regrowth in the spinal cord area ... an FDA approved polymer, the scaffold ultimately breaks down ... the human body. NVIV has recently attracted significant investor ...
Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3
... Reportlinker.com announces that a new market research report ... - Drugs, Markets and Companies ... role of neuroprotection in acute disorders such as stroke ... in chronic diseases such as neurodegenerative disorders because many ...
... 2010 The Coordination for the Improvement of Personnel ... ceremony, celebrating the 10th anniversary of Portal de Periodicos. ... other international publishers who are part of the Portal. ... with access to its Micromedex® solutions, which include evidence-based ...
Cached Medicine Technology:Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 2Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 3Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 4Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 5Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 6Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 7Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 8Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 9Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 10Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 11Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 12Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 13Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 14Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 15Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 16Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 17Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 18Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 19Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 20Higher Education Foundation in Brazil Seals Its Continued Relationship with Thomson Reuters for Academic Healthcare Content 2
(Date:10/20/2014)... Allegheny General Hospital’s (AGH) Cardiovascular Institute is offering ... a damaged mitral valve as the heart continues to ... Abbott Vascular , is designed to treat degenerative ... which the heart’s mitral valve leaflets fail to close ... left ventricle into the left atrium. The heart must ...
(Date:10/20/2014)... ASCNYC (ascnyc.org) is a New ... Yorkers living with HIV/AIDS and other chronic conditions ... and self-sufficiency. Each year, ASCNYC spotlights selected “Positive ... their tireless efforts. , Savills Studley ... been selected as this year’s honoree for sharing ...
(Date:10/20/2014)... ATLANTA, Ga. (PRWEB) October 20, 2014 ... networking and relationship-marketing firm, announced today that William ... been named the 2014 ISE® Luminary Leadership Award ... celebrates the achievements of an outstanding leader and ... stewardship and contributions in advancing the information security ...
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
(Date:10/20/2014)... WA (PRWEB) October 20, 2014 My ... workflow management software application. The new module enables ... patients receive full life-cycle quality care. , This application ... others within their practice, attach a to-do item to ... fit, and even set up reoccurring reminders for follow-ups. ...
Breaking Medicine News(10 mins):Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2
... the Second Fiscal ... Quarter ... Fiscal 2008 Guidance, MOUNTAIN VIEW, Calif., Oct. 25 Pharsight,Corporation (OTC Bulletin ... drug development, today,announced financial results for its second quarter of fiscal 2008, ended,September ...
... kids missed back-to-school crush, they can still get the ... News) -- At the beginning of every school year, ... vaccine, with demand sometimes outpacing supply. , It doesn,t ... potentially lifesaving shot is available year-round. , While August ...
... Trial to Evaluate an Immunomodulatory Cell Therapy Product For ... October 25, 2007 The Juvenile Diabetes Research ... (NASDAQ:OSIR) to support a Phase II clinical trial using ... regenerate insulin-producing cells in patients newly diagnosed with type ...
... Oct. 25 John W. Walsh, president of ... the 53rd International,Respiratory Congress of the American Association ... AARC is a 43,000-member association,representing respiratory therapists involved ... ages who suffer a range of respiratory illness,including ...
... MELVILLE, N.Y., Oct. 25 Gentiva Health,Services, Inc. (Nasdaq: ... health and related services, announced today that it is,scheduled ... November 7,2007 at the CIBC World Markets 18th Annual ... available to the public via a live audio web ...
... In its first-ever,single-topic special issue, the Harvard ... offers advice aimed at unscrambling the mixed,messages about ... on nutrition, its recommendations include:, -- You ... with exercise,fruits and vegetables are the closest thing ...
Cached Medicine News:Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 2Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 3Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 4Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 5Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 6Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 7Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 8Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 9Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 10Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 11Health News:Pharsight Achieves $7.3 Million in Quarterly Revenue 12Health News:Meningitis Shot Available, Effective Year-Round 2Health News:Meningitis Shot Available, Effective Year-Round 3Health News:JDRF Partners with Osiris to evaluate an immunomodulatory cell therapy product for type 1 diabetes 2Health News:Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities 2Health News:Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities 3Health News:Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York 2Health News:Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York 3Health News:All About Heart-Healthy Eating: The Harvard Heart Letter Devotes an Issue to Nutrition 2
Curved shafts with 2 mm angled platform. Wide serrated handle with dull finish....
Curved shafts with 3.5 mm angled platform and dull finish. Wide serrated handle with dull finish....
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle....
Grooved roller, on which knife oscillates....
Medicine Products: